AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
The role of high-dose therapy (HDT) followed by autologous stem cell transplantation (ASCT) in the treatment armamentarium of aggressive B- and T-cell non-Hodgkin lymphoma (NHL) is still a matter of debate. In the pre-Rituximab era, the PARMA study demonstrated the superiority of HDT/ASCT over conve...
Saved in:
Main Authors: | Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2012-11-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/359 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
by: Anna Locasciulli, et al.
Published: (2009-11-01) -
CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01) -
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma—Is There Still a Role?
by: Michael Daunov, et al.
Published: (2024-10-01) -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01) -
EPSTEIN-BARR VIRUS RELATED LYMPHOPROLIFERATIONS AFTER STEM CELL TRANSPLANTATION
by: Simona Sica, et al.
Published: (2009-12-01)